Lei Zhao

6PUBLICATIONS
17CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 16, 2023
Efficacy and cost-effectiveness analysis of pretreatment percutaneous endoscopic gastrostomy in unresectable locally advanced esophageal cancer patients treated with concurrent chemoradiotherapy (GASTO 1059).

XinLei Ai, PengXin Zhang, XinMin Xie

|Feb 11, 2023
Identification on surrogating overall survival with progression-free survival of first-line immunochemotherapy in advanced esophageal squamous cell carcinoma-an exploration of surrogate endpoint.

Zewei Zhang, Chunxia Xie, Tiantian Gao

|Apr 18, 2022
Progression-free survival at 3 years is a reliable surrogate for 5-year overall survival for patients suffering from locally advanced esophageal squamous cell carcinoma.

Yu-Xian Yang, Yu-Zhen Zheng, Tian-Tian Gao

|Jun 30, 2021
Induction chemotherapy followed by definitive chemoradiotherapy versus chemoradiotherapy alone in esophageal squamous cell carcinoma: a randomized phase II trial.

Shiliang Liu, Liling Luo, Lei Zhao

|Aug 08, 2019
Stereotactic Body Radiotherapy as a Salvage Therapy after Incomplete Radiofrequency Ablation for Hepatocellular Carcinoma: A Retrospective Propensity Score Matching Study.

Yang-Xun Pan, Mian Xi, Yi-Zhen Fu

|Dec 19, 2018
Combination Therapy after TACE for Hepatocellular Carcinoma with Macroscopic Vascular Invasion: Stereotactic Body Radiotherapy versus Sorafenib.

Lujun Shen, Mian Xi, Lei Zhao

Pageof 1

Frequent Collaborators

2 joint publications

Yujia Zhu

2 joint publications

Yong Yang

1 joint publications

Lujun Shen

1 joint publications

Qifeng Chen